-
Likelihood of Approval and Phase Transition Success Rate Model - Sodium Calcium Edetate + Tobramycin in Pseudomonas aeruginosa Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sodium Calcium Edetate + Tobramycin in Pseudomonas aeruginosa Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sodium Calcium Edetate + Tobramycin in...
-
Likelihood of Approval and Phase Transition Success Rate Model - Mebufotenin in Unspecified Psychiatric Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mebufotenin in Unspecified Psychiatric Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mebufotenin in Unspecified Psychiatric Disorders Drug Details: Mebufotenin (GH-001) is...
-
Likelihood of Approval and Phase Transition Success Rate Model - LTX-608 in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTX-608 in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LTX-608 in Coronavirus Disease 2019 (COVID-19) Drug Details: Nafamostat...
-
Likelihood of Approval and Phase Transition Success Rate Model - PB-1902 in Opioid-Induced Constipation (OIC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-1902 in Opioid-Induced Constipation (OIC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PB-1902 in Opioid-Induced Constipation (OIC) Drug Details: PB-1902 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - TRB-051 in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRB-051 in Autoimmune Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TRB-051 in Autoimmune Disorders Drug Details: TRB-051 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - BC-3195 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BC-3195 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BC-3195 in Metastatic Ovarian Cancer Drug Details: BC-3195 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - WSD-0628 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - WSD-0628 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. WSD-0628 in Glioblastoma Multiforme (GBM) Drug Details: WSD-0628 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - KT-621 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-621 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-621 in Atopic Dermatitis (Atopic Eczema) Drug Details: KT-621...
-
Likelihood of Approval and Phase Transition Success Rate Model - RAP-219 in Peripheral Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RAP-219 in Peripheral Neuropathic Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RAP-219 in Peripheral Neuropathic Pain Drug Details: RAP-219 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Substance (Drug) Abuse
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Substance (Drug) Abuse report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Substance (Drug) Abuse Drug Details: Psilocybin (PEX010) is...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.